Dioxaphetyl butyrate

From WikiMD's WELLNESSPEDIA

A synthetic opioid analgesic

Dioxaphetyl butyrate is a synthetic opioid analgesic that was developed in the mid-20th century. It is known for its potent analgesic properties and is used in the management of moderate to severe pain.

Chemical Structure[edit]

Dioxaphetyl butyrate is chemically classified as an opioid, which means it is a compound that binds to opioid receptors in the central nervous system. The chemical structure of Dioxaphetyl butyrate includes a phenyl group and a butyrate ester, which contribute to its pharmacological activity.

Pharmacology[edit]

Dioxaphetyl butyrate acts primarily as an agonist at the mu-opioid receptor, which is responsible for its analgesic effects. By binding to these receptors, it inhibits the transmission of pain signals in the nervous system. This mechanism is similar to that of other opioids, such as morphine and fentanyl.

Medical Uses[edit]

Dioxaphetyl butyrate is used in the treatment of moderate to severe pain, particularly in cases where other analgesics are ineffective. It is important to note that, like other opioids, it has the potential for abuse and dependence, and its use is typically restricted to situations where alternative treatments are not suitable.

Side Effects[edit]

Common side effects of Dioxaphetyl butyrate include nausea, vomiting, constipation, and drowsiness. More serious side effects can include respiratory depression, which is a potentially life-threatening condition where breathing becomes inadequate.

Regulation[edit]

Due to its potential for abuse, Dioxaphetyl butyrate is classified as a controlled substance in many countries. Its distribution and use are strictly regulated to prevent misuse and addiction.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.